Evidence map›Paper›PMID 33195255›Full record

ArticleFrontiers in cell and developmental biology2020

Activity of Human Apurinic/Apyrimidinic Endonuclease APE1 Toward Damaged DNA and Native RNA With Non-canonical Structures.

Anastasia T Davletgildeeva, Alexandra A Kuznetsova, Olga S Fedorova, Nikita A Kuznetsov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Position-Dependent Effects of AP Sites Within anInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. PromotersRSC chemical biology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Direct and Base Excision Repair-Mediated Regulation of a GC-RichInternational journal of molecular sciences · 2021
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Anastasia T DavletgildeevaInstitute of Chemical Biology and Fundamental Medicine of the SB RAS, Novosibirsk, Russia.
Alexandra A KuznetsovaInstitute of Chemical Biology and Fundamental Medicine of the SB RAS, Novosibirsk, Russia.
Olga S FedorovaInstitute of Chemical Biology and Fundamental Medicine of the SB RAS, Novosibirsk, Russia.
Nikita A KuznetsovInstitute of Chemical Biology and Fundamental Medicine of the SB RAS, Novosibirsk, Russia.
Siberian Branch of the Russian Academy of Sciences · RUInstitute of Chemical Biology and Fundamental Medicine · RUNovosibirsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary role of apurinic/apyrimidinic (AP) endonuclease APE1 in human cells is the cleavage of the sugar phosphate backbone 5' to an AP site in DNA to produce a single-strand break with a 5'-deoxyribose phosphate and 3'-hydroxyl end groups. APE1 can also recognize and incise some damaged or modified nucleotides and possesses some minor activities: 3'-5' exonuclease, 3'-phosphodiesterase, 3'-phosphatase, and RNase H. A molecular explanation for the discrimination of structurally different substrates by the single active site of the enzyme remains elusive. Here, we report a mechanism of target nucleotide recognition by APE1 as revealed by the results of an analysis of the APE1 process involving damaged DNA and native RNA substrates with non-canonical structures. The mechanism responsible for substrate specificity proved to be directly related to the ability of a target nucleotide to get into the active site of APE1 in response to an enzyme-induced DNA distortion.

Indexed as

AP endonucleaseDNA repairnon-B-DNAnucleotide recognitionquadruplex

Identifiers

PMID33195255
PMCPMC7662432
OpenAlexW3096968888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.